The recent challenges in global chains have highlighted the necessity of securing vital medications like Ivermectin. Dependence on overseas producers exposes countries to potential vulnerabilities, including shipping delays, expense fluctuations, and even political concerns. Shifting towards domestic procurement of Ivermectin offers a multitude of